Skip to content
Credit reportVerdict and grounds
Made on 20-11-2026 at 22:55
Reference CK-1002392357-20261120

Endoline

ActivePrivate limited company1002.392.357Gagelveld 29, 2275 Lille
Specialist medical practice (NACE 86220) · founded in 2023 · financial year to 30 June · one director · accounts in the micro format

Sources: the KBO register on 20-11-2026; the National Bank, annual accounts to 30-06-2026 filed on 02-11-2026; the Belgian Official Gazette, latest deed of 21-11-2023.

Credit verdict
Checked score 2026
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 24,225 micro companies in the human health sector (NACE 86) is below 0.1%.
Gross margin
€187,888
▲ 83.7% against 2025
Net result
€134,807
▲ 83.9% against 2025
Equity
€240,271
▲ 128% against 2025
Cash
€189,768
▲ 183% against 2025

Grounds

the facts the verdict rests on, each with its source
  1. Endoline made a profit in every financial year since 2024. The profit of 2026, €134,807, is the highest so far.Annual accounts 2024 to 2026 page 2
  2. Equity stands at €240,271, or 76.5% of the balance sheet total of €314,283. In 2025, the solvency of 62.3% was higher than at 49% of the 21,373 companies filing micro accounts in human health (NACE 86).Annual accounts to 30-06-2026 page 2
  3. The last three annual accounts came in on time. The accounts to 30-06-2026 were filed 90 days before the end of the term.National Bank, filing of 02-11-2026 page 5

Representation

The signing rule is in the founding deed of 21-11-2023.

Articles of association, Belgian Official Gazette of 21-11-2023, deed 23429633

Ownership

The accounts in the micro format list no shareholders. founded Endoline by deed of 21-11-2023. There is one other shareholder.

Deed of 21-11-2023

Endoline · 1002.392.357 · credit report of 20-11-2026Page 1 of 6
Endoline1002.392.357 · report of 20-11-2026

Financial situation

Annual accounts 2024 to 2026, as filed with the National Bank

Gross margin and net resultin euro

202438,1192025102,2952026187,888202429,179202573,2852026134,807
gross marginnet result

Equity and debtsin euro

202420252026240,27174,011
equitydebts

Cashin euro

20246,325202566,9412026189,768
on the balance sheet date
Financial year20247 months20252026Trend
Results
Gross margin€38,119€102,295€187,888
Operating result€36,960€93,204€174,753
Net result€29,179€73,285€134,807
Balance sheet at the closing date
Equity€32,179€105,465€240,271
Debts€10,595€63,885€74,011
Debts due after more than one year-€35,366€25,704
Debts due within one year€10,595€28,519€48,307
Cash€6,325€66,941€189,768
Balance sheet total€42,774€169,349€314,283
Ratios
Solvency75.2%62.3%76.5%
Liquidity4.043.955.59

Source: Annual accounts to 30-06-2026, micro format, filed on 02-11-2026 (2026-00600474); Annual accounts to 30-06-2025, micro format, filed on 17-12-2025 (2025-00586480); Annual accounts 2024, filed on 15-11-2024 (2024-00600523).

The operating result of 2026 is 87% higher than in 2025.

Debts rose by €10,127 in 2026.

The annual accounts to 30-06-2026 state no amount of overdue tax or social security (RSZ) debts.

Endoline states no turnover; the micro format does not require it. The gross margin, what is left after purchases, rose from €102,295 to €187,888.

Endoline · 1002.392.357 · credit report of 20-11-2026Page 2 of 6
Endoline1002.392.357 · report of 20-11-2026

Board, signature and ownership

Position on 20-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

The signing rule is in the founding deed of 21-11-2023.

Articles of association, Belgian Official Gazette of 21-11-2023, deed 23429633

Board

one director in office
Directorsince 16-11-2023
deed of 21-11-2023

Ownership and group

Shareholders

The accounts in the micro format list no shareholders. founded Endoline by deed of 21-11-2023. holds all 100 shares.

Deed of 21-11-2023

Endoline · 1002.392.357 · credit report of 20-11-2026Page 3 of 6
Endoline1002.392.357 · report of 20-11-2026

Holdings

Endoline has 1 holding (own accounts to 30-06-2025).

Country Company Equity Result
Belgium 1
BE 11.07% €20,949 result -€6,491

Source: List of holdings in its own accounts to 30-06-2025. Every holding stands with its own latest accounts.

Endoline · 1002.392.357 · credit report of 20-11-2026Page 4 of 6
Endoline1002.392.357 · report of 20-11-2026

Events and comparison

The last 24 months, newest first

Annual accounts 2026 filed, 90 days before the deadline.

NBB filing

Highest result from 2024 to 2026. The operating result of €174,753 and the net result of €134,807 are both a record.

Financial

Equity above €200,000. With a profit in every financial year since 2024, equity grows to €240,271.

Financial

Annual accounts 2025 filed, 45 days before the deadline.

NBB filing

Equity above €100,000. With a profit in every financial year since 2024, equity grows to €105,465.

Financial

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as Endoline has now: micro, 2 to 5 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 95.7% were still trading, 2.5% had stopped another way and 1.8% had gone bankrupt.

still trading 95.7% stopped another way 2.5% bankrupt 1.8%

In 2025, the return on assets of Endoline, 43.3%, was higher than at 78% of the 21,223 companies filing micro accounts in human health (NACE 86).

Other findings

Peppol

Reachable for e-invoices since 11-12-2025, under 0208:1002392357.

Sanctions lists

Endoline · 1002.392.357 · credit report of 20-11-2026Page 5 of 6
Endoline1002.392.357 · report of 20-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units20-11-2026KBO 1002.392.357
National Bank of BelgiumAnnual accounts to 30-06-2026, micro format02-11-20262026-00600474
National Bank of BelgiumAnnual accounts to 30-06-2025, micro format17-12-20252025-00586480
National Bank of BelgiumAnnual accounts 2024 to 202415-11-20242024-00600523
Belgian Official GazetteFounding deed with the articles of association21-11-2023deed 23429633
Peppol DirectoryRegistration for e-invoices11-12-20250208:1002392357
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies20-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 20-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

Endoline · 1002.392.357 · credit report of 20-11-2026Page 6 of 6